Cancer Letters
Volume 238, Issue 2 , Pages 168-179 , 18 July 2006

APAF-1 signaling in human melanoma

Received 11 June 2005 ,Accepted 18 June 2005.

References 

  1. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, et al. Final version of the American Joint Committee on cancer staging system for cutaneous melanoma. J. Clin. Oncol. 2001;19:3635–3648
  2. Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on cancer melanoma staging system. J. Clin. Oncol. 2001;19:3622–3634
  3. Soengas MS, Lowe SW. Apoptosis and melanoma chemoresistance. Oncogene. 2002;22:3138–3151
  4. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70
  5. Okada H, Mak TW. Pathways of apoptotic and non-apoptotic death in tumour cells. Nature Rev. Cancer. 2004;4:592–603
  6. Igney FH, Krammer PK. Death and anti-death: tumour resistance to apoptosis. Nature Rev. Cancer. 2002;2:277–288
  7. Ivanon VN, Bhoumik A, Ronai Z. Death receptors and melanoma resistance to apoptosis. Oncogene. 2003;22:3152–3161
  8. Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell. 2004;116:205–219
  9. Green DR. Apoptotic pathways: ten minutes to dead. Cell. 2005;121:671–674
  10. Breckenridge DG, Germain M, Mathai JP, Nguyen M, Shore GC. Regulation of apoptosis by endoplasmic reticulum pathways. Oncogene. 2003;22:8608–8618
  11. Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA, et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature. 2000;403:98–103
  12. Kim R. Recent advances in understanding the cell death pathways activated by anticancer therapy. Cancer. 2005;103:1552–1560
  13. Milhas D, Cuvillier O, Therville N, Clave P, Thomsen M, Levade T, et al. Caspase-10 triggers bid cleavage and caspase cascade activation in FasL-induced apoptosis. J. Biol. Chem. 2005;280:19836–19842
  14. Muller M, Strand S, Hug H, Heinemann EM, Walczak H, Hofmann WJ, et al. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J. Clin. Invest. 1997;99:403–413
  15. Insinga A, Monestiroli S, Ronzoni S, Gelmetti V, Marchesi F, Viale A, et al. Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway. Nat. Med. 2005;11:71–76
  16. Daniotti M, Oggionni M, Ranzani T, Vallacchi V, Campi V, Di D, et al. BRAF alterations are associated with complex mutational profiles in malignant melanoma. Oncogene. 2004;23:5968–5977
  17. Rodolfo M, Daniotti M, Vallacchi V. Genetic progression of metastatic melanoma. Cancer Lett. 2004;214:133–147
  18. Vivanco I, Sawyers CL. The phosphatidylinositol-3-kinase-AKT pathway in human cancer. Nat. Rev. Cancer. 2002;2:489–501
  19. Chin L. The genetics of malignant melanoma: lessons from mouse and man. Nat. Rev. Cancer. 2003;3:559–570
  20. Wu H, Goel V, Haluska FG. PTEN signaling pathways in melanoma. Oncogene. 2003;22:3113–3122
  21. Frank NY, Margaryan A, Huang Y, Schatton T, Waaga-Gasser AM, Gasser M, et al. ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res. 2005;65:4320–4333
  22. Zhang XD, Zhang XY, Gray CP, Nguyen T, Hersey P. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria. Cancer Res. 2001;61:7339–7348
  23. Vucic D, Stennicke HR, Pisabarro MT, Salvesen GS, Dixit VM. ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas. Curr. Biol. 2000;10:1359–1366
  24. Du C, Fang M, Li Y, Li L, Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell. 2000;102:33–42
  25. Zhang XD, Borrow JM, Zhang XY, Nguyen T, Hersey P. Activation of ERK1/2 protects melanoma cells from TRAIL-induced apoptosis by inhibiting Smac/DIABLO release from mitochondria. Oncogene. 2003;22:2869–2881
  26. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, et al. Inhibition of death receptor signals by cellular FLIP. Nature. 1997;388:190–195
  27. Chawla-Sarkar M, Bae SI, Reu FJ, Jacobs BS, Lindner DJ, Borden EC. Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis. Cell Death Differ. 2004;11:915–923
  28. Gradilone A, Gazzaniga P, Ribuffo D, Scarpa S, Cigna E, Vasaturo F, et al. Survivin, bcl-2, bax, and bcl-X gene expression in sentinel lymph nodes from melanoma patients. J. Clin. Oncol. 2003;15:306–312
  29. Zhang XD, Franco A, Myers K, Gray C, Nguyen T, Hersey P. Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma. Cancer Res. 1999;59:2747–2753
  30. Soengas MS, Capodieci P, Polsky D, Mora J, Esteller M, Opitz-Araya X, et al. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature. 2001;409:207–211
  31. Yuan JY, Horvitz RH. Genetics mosaic analysis of ced-3 and ced-4, two genes that control programmed cell death in the nematode C. elegans. Dev. Biol. 1990;138:33–41
  32. Hengartner MO, Ellis RE, Horvitz RH. Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature. 1992;356:494–499
  33. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell. 1997;90:405–413
  34. Adrain C, Slee EA, Harte MT, Martin SJ. Regulation of apoptotic protease activating factor-1 oligomerization and apoptosis by the WD-40 repeat region. J. Biol. Chem. 1999;274:20855–20860
  35. Fu WN, Kelsey SM, Newland AC, Jia L. Apaf-1XL is an inactive isoform compared with Apaf-1L. Biochem. Biophys. Res. Commun. 2001;282:268–272
  36. Hahn C, Hirsch B, Janke D, Durkop H, Stein H. Three new types of Apaf-1 in mammalian cells. Biochem. Biophys. Res. Commun. 1999;261:746–749
  37. Benedict MA, Hu Y, Inohara N, Nunez G. Expression and functional analysis of Apaf-1 isoforms. Extra Wd-40 repeat is required for cytochrome c binding and regulated activation of procaspase-9. J. Biol. Chem. 2000;275:8461–8468
  38. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 1997;91:479–489
  39. Srinivasula SM, Ahmad M, Fernandes-Alnemri T, Alnemri ES. Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol. Cell. 1998;1:949–957
  40. Zou H, Li Y, Liu X, Wang X. An APAF-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 1999;274:11549–11556
  41. Acehan D, Jiang X, Morgan DG, Heuser JE, Wang X, Akey CW. Three-dimensional structure of the apopotosome: implications for assembly, procaspase-9 binding and activation, Mol. Cell. 2002;9:423–432
  42. Riedl SJ, Li W, Chao Y, Schwarzenbacher R, Shi Y. Structure of the apoptotic protease-activating factor 1 bound to ADP. Nature. 2005;434:926–933
  43. Chu ZL, Pio F, Xie Z, Welsh L, Krajewska M, Krajewski S, et al. A novel enhancer of the APAF-1 apoptosome involved in cytochrome-c-dependent caspase activation and apoptosis. J. Biol. Chem. 2001;276:9239–9245
  44. Sakai T, Liu L, Teng X, Mukai-Sakai R, Shimada H, Kaji R, et al. Nucling recruits APAF-1/pro-caspase-9 complex for the induction of stress-induced apoptosis. J. Biol. Chem. 2004;279:41131–41140
  45. Bratton SB, Walker G, Srinivasula SM, Sun XM, Butterworth M, Alnemri ES, et al. Recruitment, activation and retention of caspase-9 and -3 by Apaf-1 apoptosome and associated XIAP complexes. EMBO J. 2001;20:998–1009
  46. Ekert PG, Silke J, Hawkins CJ, Verhagen AM, Vaux DL. DIABLO promotes apoptosis by removing MIHA/XIAP from processed caspase-9. J. Cell Biol. 2001;152:483–490
  47. Hegde R, Srinivasula SM, Zhang Z, Wassell R, Mukattash R, Cilenti L, et al. Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J. Biol. Chem. 2002;277:432–438
  48. Bruey JM, Ducasse C, Bonniaud P, Ravagnan L, Susin SA, Diaz-Latoud C, et al. Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat. Cell Biol. 2000;2:645–652
  49. Saleh A, Srinivasula SM, Balkir L, Robbins PD, Alnemri ES. Negative regulation of the Apaf-1 apoptosome by Hsp70. Nat. Cell Biol. 2000;2:476–483
  50. Beere HM, Wolf BB, Cain K, Mosser DD, Mahboubi A, Kuwana T, et al. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat. Cell Biol. 2000;2:469–475
  51. Pandey P, Saleh A, Nakazawa A, Kumar S, Srinivasula SM, Kumar V. Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90. EMBO J. 2000;19:4310–4322
  52. Martin MC, Allan LA, Lickrish M, Sampson C, Morrice N, Clarke PR. Protein kinase A regulates caspase-9 activation by Apaf-1 downstream of cytochrome c. J. Biol. Chem. 2005;280:15449–15455
  53. Yoshida H, Kong YY, Yoshida R, Elia AJ, Hakem A, Hakem R, et al. Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell. 1998;94:739–750
  54. Cecconi F, Alvarez-Bolado G, Meyer BI, Roth KA, Gruss P. Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development. Cell. 1998;94:727–737
  55. Hao Z, Duncan GS, Chang CC, Elia A, Fang M, Wakeham A, et al. Specific ablation of the apoptotic functions of cytochrome C reveals a differential requirement for cytochrome C and Apaf-1 in apoptosis. Cell. 2005;121:579–591
  56. Soengas MS, Alarcon RM, Yoshida H, Giaccia AJ, Hakem R, Mak TW, et al. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science. 1999;284:156–159
  57. Lassus P, Opitz-Araya X, Lazebnik Y. Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science. 2002;297:1352–1354
  58. Marsden VS, O'Connor L, O'Reilly LA, Silke J, Metcalf D, Ekert PG, et al. Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome. Nature. 2002;419:634–637
  59. Belmokhtar CA, Hillion J, Dudognon C, Fiorentino S, Flexor M, Lanotte M, et al. Apoptosome-independent pathway for apoptosis. Biochemical analysis of APAF-1 defects and biological outcomes. J. Biol. Chem. 2003;278:29571–29578
  60. Ho AT, Li QH, Hakem R, Mak TW, Zacksenhaus E. Coupling of caspase-9 to Apaf-1 in response to loss of pRb or cytotoxic drugs is cell-type specific. EMBO J. 2004;28:460–472
  61. Ekert PG, Read SH, Silke J, Marsden VS, Kaufmann H, Hawkins CJ, et al. Apaf-1 and caspase-9 accelerate apoptosis, but do not determine whether factor-deprived or drug-treated cells die. J. Cell Biol. 2004;165:835–842
  62. Baldi A, Santini D, Russo P, Catricalà C, Amantea A, Picardo M, et al. Analysis of APAF-1 expression in human cutaneous melanoma progression. Exp. Dermatol. 2004;13:93–97
  63. Dai DL, Martinka M, Bush JA, Li G. Reduced Apaf-1 expression in human cutaneous melanomas. Br. J. Cancer. 2004;91:1089–1095
  64. Mustika R, Budiyanto A, Nishigori C, Ichihashi M, Ueda M. Decreased expression of Apaf-1 with progression of melanoma. Pigment Cell Res. 2005;18:59–62
  65. Fujimoto A, Takeuchi H, Taback B, Hsueh EC, Elashoff D, Morton DL, et al. Allelic imbalance of 12q22-23 associated with APAF-1 locus correlates with poor disease outcome in cutaneous melanoma. Cancer Res. 2004;64:2245–2250
  66. Fujimoto A, O'Day SJ, Taback B, Elashoff D, Hoon DS. Allelic imbalance on 12q22-23 in serum circulating DNA of melanoma patients predicts disease outcome. Cancer Res. 2004;64:4085–4088
  67. Watanabe T, Hirota Y, Arakawa Y, Fujisawa H, Tachibana O, Hasegawa M, et al. Frequent LOH at chromosome 12q22-23 and Apaf-1 inactivation in glioblastoma. Brain Pathol. 2003;3:431–439
  68. Umetani N, Fujimoto A, Takeuchi H, Shinozaki M, Bilchik AJ, Hoon DS. Allelic imbalance of APAF-1 locus at 12q23 is related to progression of colorectal carcinoma. Oncogene. 2004;23:8292–8300
  69. Leo C, Richter C, Horn LC, Schutz A, Pilch H, Hockel M. Expression of Apaf-1 in cervical cancer correlates with lymph node metastasis but not with intratumoral hypoxia. Gynecol. Oncol. 2005;97:602–606
  70. Besse B, Cande C, Spano JP, Martin A, Khayat D, Le Chevalier T, et al. Nuclear localization of apoptosis protease activating factor-1 predicts survival after tumor resection in early-stage non-small cell lung cancer. Clin. Cancer Res. 2004;10:5665–5669
  71. Zanon M, Piris A, Bersani I, Vegetti C, Molla A, Scarito A, et al. Apoptosis protease activator protein-1 expression is dispensable for response of human melanoma cells to distinct proapoptotic agents. Cancer Res. 2004;64:7386–7394
  72. Robles AI, Bemmels NA, Foraker AB, Harris CC. APAF-1 is a transcriptional target of p53 in DNA damage-induced apoptosis. Cancer Res. 2001;61:6660–6664
  73. Ho CK, Bush JA, Li G. Tissue-specific regulation of Apaf-1 expression by p53. Oncol. Rep. 2003;10:1139–1143
  74. Svingen PA, Loegering D, Rodriquez J, Meng XW, Mesner PW, Holbeck S, et al. Components of the cell death machine and drug sensitivity of the National Cancer Institute Cell Line. Clin. Cancer Res. 2004;10:6807–6820
  75. Holleman A, den Boer ML, Kazemier KM, Beverloo HB, von Bergh AR, Janka-Schaub GE, et al. Decreased PARP and procaspase-2 protein levels are associated with cellular drug resistance in childhood acute lymphoblastic leukemia. Blood. 2005;
  76. Fulda S, Meyer E, Friesen C, Susin SA, Kroemer G, Debatin KM. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis. Oncogene. 2001;20:1063–1075
  77. Martinsson P, Liminga G, Nygren P, Larsson R. Characteristics of etoposide-induced apoptotic cell death in the U-937 human lymphoma cell lines. Anticancer Drugs. 2001;12:699–705
  78. Shinoura N, Sakurai S, Asai A, Kirino T, Hamada H. Co-transduction of APAF-1 and caspase-9 augments etoposide-induced apoptosis in U-373MG glioma cells. Jpn. J. Cancer Res. 2001;92:467–474
  79. Jia L, Srinivasula SM, Liu FT, Newland AC, Fernandes-Alnemri T, Alnemri ES, et al. Apaf-1 protein deficiency confers resistance to cytochrome c-dependent apoptosis in human leukemic cells. Blood. 2001;98:414–421
  80. Sun Y, Orrenius S, Pervaiz S, Fadeel B. Plasma membrane sequestration of apoptotic protease-activating factor-1 in human B lymphoma cells: a novel mechanism of chemoresistance. Blood. 2005;105:4070–4077
  81. Brunelle JK, Chandel NS. Oxygen deprivation induced cell death: an update. Apoptosis. 2002;7:475–482
  82. Hammond EM, Gaccia AJ. The role of p53 in hypoxia-induced apoptosis. Biochem Biophys. Res. Commun. 2005;331:718–727
  83. Cho DH, Hong YM, Lee HJ, Woo HN, Pyo JO, Mak TW, et al. Induced inhibition of ischemic/hypoxic injury by APIP, a novel Apaf-1-interacting protein. J. Biol. Chem. 2004;279:39942–39945
  84. Weinmann M, Belka C, Guner D, Goecke B, Muller I, Bamberg M, et al. Array-based comparative gene expression analysis of tumor cells with increased apoptosis resistance after hypoxic selection. Oncogene. 2005;0

PII: S0304-3835(05)00592-6

doi: 10.1016/j.canlet.2005.06.034

Cancer Letters
Volume 238, Issue 2 , Pages 168-179 , 18 July 2006

Article Tools

* Image Usage & Resolution